Abstract
Introduction
Tissue engineering (TE) [4] . Several reviews and research articles [5, 6] [3, 14, 15] [25, 26] and collagen gels [18, 27] [30] . In particular, their composition varies from batch to batch which may affect experimental reproducibility [36, 37] [38] . Hydrogels are also being increasingly used as 3D cell culture models as, compared to rigid polymeric scaffolding materials, they may more closely mimic the actual physiological environment in which cells reside in vivo [39] . Recent advances in bioengineering and biomaterials science have enabled functionalization of (semi)-synthetic hydrogels to include features found in the natural ECM [7] [8] [9] 40] and allow systematic studying their involvement in cancer development. [41] . Commercially available Extragel, consisting of chemically modified hyaluronan and gelatin cross-linked with polyethylene glycol (PEG), has potential as a tunable 3D cell culture matrix in cancer cell research [42, 43] . These matrices have been already utilized as delivery vehicle for tumour cells for the creation of orthotopic human tumour xenografts in animal models [44] [45] [46] [47] . Zhang [48, 49] . These matrices have been applied in a range of in vitro and in vivo studies [50, 51] , and the commercially available Puramatrix, originally developed in Zhang laboratories (Boston, MA, USA), have been also used as 3D cell culture matrices in cancer research [52, 53] .
Physiological and structural aspects of 2D versus 3D culture in cancer research

All cells are embedded in a 3D microenvironment in the body. However, for many decades nearly all tissue cells including most tumour cells have been studied in two-dimensional (2D) Petri dishes, 2D multi-well plates or 2D glass slides coated with various substrata [14]. However, cells in tissues reside within multicellular 3D environment consisting of a range of ECM macromolecules (including many types of collagens, proteoglycans, laminin and other matrix proteins) depending on the type of tissue. Specifically, the native ECM is a heterogeneous collection of covalent and non-covalent molecular interactions comprised primarily of proteins and glycosaminoglycans (GACs). Covalent bonds connect chondroitin sulphate, heparan sulphate, and other sulphated GAGs to core proteins to give proteooglycans (PGs). Non-covalent interactions include electrostatic associations with ions, hydration of the polysaccharide chains, binding of link modules of PGs to hyaluronan and triple helix formation to generate collagen fibrils. They allow both attachment between cells and the basal membrane and access to oxygen, hormones and nutrients as well as removal of waste products and other cell types associated in tissues
New tissue engineering-routed scaffolds for 3D culture
As outlined in the previous section microenvironmental conditions play an important role in tumorigenesis. Accordingly, controlling the extracellular milieu in which cancer cells are cultured may significantly contribute to elucidating mechanisms of cancer formation and growth, as well as sensitivity to antitumour drugs. In this context, currently used naturally derived gold standard matrices for 3D cancer cell cultures show some limitations mainly concerning their reproducibility and the flexibility of the design and modification of their characteristics. Emerging biomaterials-based approaches in regenerative medicine and tissue engineering have pioneered the production of scaffolding matrices with malleable characteristics, thereby enabling cell culture in more controllable 3D microenvironments. In this section, we focus on examples of materials originally conceived for in vivo tissue regeneration that have been recently applied for cancer research as 3D cell culture models. Biologically passive, porous and rigid scaffolds made from hydrolytically degradable poly (lactide-co-glycolide) acid polymers were used as 3D structures to culture human oral squamous carcinoma cells. Cancer cells cultured in these 3D structures gave rise to tumour-like masses with characteristics (e.g. growth, expression of tumour specific markers, etc.) that, in contrast to monolayer and -to some extentmatrigel-cultured cells, expressed a very similar behaviour compared to animal models
For instance RGD-functionalized alginate gels were used as 3D cell culture models to specifically explore the implication of the engagement of tumour cell integrins in angiogenic signalling in vitro and in vivo
Another synthetic hydrogel system, arguably one of the most versatile in term of modularly design biological, biochemical and mechanical properties, has been pioneered by Hubbell, Lutolf and coworkers [9, 54, 55] . These biomimetic PEG-based hydrogels have shown in vivo performance comparable to naturally derived matrices [56] and high design flexibility of their characteristics enabling to systematically study mechanisms governing cell migration in 3D [54, 57] . We have adopted these hydrogel systems in our group to explore the behaviour of prostate cancer cells cultured in 3D. In particular, we are employing biomimetic hydrogels that are formed from peptide functionalized multi-arm PEG via the FXIII-catalysed cross-linking mechanism [55, 58] . By means of the same reaction during material formation bioactive molecules (e.g. RGD [58] and growth factors [55] can be stably incorporated in the hydrogels. In addition, sensitivity of these matrices to proteolytic degradation can be precisely controlled through design of specific matrix metalloproteinase substrates within the hydrogel network [58] . 
Although the molecular composition of the ECM is a wellknown regulator of cellular responses, physical properties of the matrix in 3D models can also play surprisingly important roles. In particular, recent evidence points to direct roles for the stiffness (compliance) of the ECM in regulating multiple cellular functions. Also described as rigidity, elasticity or pliability, this property is sensed by cells through bidirectional interaction with the surrounding ECM. Cell surface integrin receptors and the
Endothelial progenitor cells and tumour vasculature
Angiogenesis and vascularization of tissues have been the focus of research wherever blood vessel formation was either desirable -such as in ischemic or bioartificial tissues -or unwanted -such as in tumours. Endothelial progenitor cells (EPCs) are precursor cells capable of differentiation into mature endothelial cells and have been shown to play an important role in angiogenesis as well as vasculogenesis in a multitude of disease states. Recent research has also highlighted their impact on angiogenetic phenomena in tissue engineering, particularly in 3D in vitro cultures.
In this context, we (Fig. 4) [60] [61, 62] . [10, 11, [67] [68] [69] . As a result, the rat arteriovenous loop model provides a unique standardized, isolated, well characterized and manipulatable environment that is vascularized over time by a defined main axis of blood vessels. We and others have [10, 11, [67] [68] [69] [70] [71] 
Angiogenesis and -as a therapeutic strategy -inhibition of angiogenesis (anti-angiogenesis) are intensively investigated in the context of tumour growth
In vivo models
